Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2573-2581

  Huang, Suyun ^a   DeGuzman, Ariel ^a   Bucana, Corazon D ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; CD31 ANTIGEN; I KAPPA B;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; DOMINANT GENE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; MELANOMA; METABOLISM; MICROCIRCULATION; MUTATION; NEOVASCULARIZATION (PATHOLOGY); NORTHERN BLOTTING; NUDE MOUSE; PHYSIOLOGY; PROMOTER REGION; TIME; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD31; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENES, DOMINANT; HUMANS; I-KAPPA B PROTEINS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MALE; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROCIRCULATION; MUTATION; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROMOTER REGIONS (GENETICS); TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033623902     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Dooley, T. Recent advances in cutaneous melanoma oncogenesis research. Oncol. Res., 6: 1-9, 1994.
2. Fidler, I. J. The biology of melanoma metastasis. In: C. M. Balch, A. N. Houghton, G. W. Milton, A. J. Sober, and S. J. Soong, eds., Cutaneous Melanoma, Vol. 2, pp. 112-129. Philadelphia, PA: J. B. Lippincott, 1992.
3. Fidler, I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes Memorial Award Lecture. Cancer Res., 50: 6130-6138, 1990.
4. Folkman, J. Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Cancer Metastasis Rev., 9: 171-174, 1990.
5. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol., 3: 65-71, 1992.
6. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
7. Fidler, I. J., and Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79: 185-188, 1994.
8. Halaban, R., Kwon, B. S., Ghosh, S., Delli Bovi, P., and Baird, A. bFGF as an autocrine growth factor for human melanomas. Oncogene Res., 3: 177-186, 1988.
9. Salven, P., Heikkila, P., and Joensuu, H. Enhanced expression of vascular endothelial growth factor in metastatic melanoma. Br. J. Cancer, 76: 930-934, 1997.
10. Erhard, H., Rietveld, F. J., van Altena, M. C., Brocker, E. B., Ruiter, D. J., and de Waal, R. M. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis. Melanoma Res., 2: S19-S26, 1997.
11. Schadendorf, D., Moller, A., Algermissen, B., Worm, M., Sticherling, M., and Czarnetzki, B. M. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol., 75: 2667-2675, 1993.
12. van Hogerlinden, M., Rozell, B. L., Ahrlund-Richter, L., and Toftgard, R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling. Cancer Res., 59: 3299-3303, 1999.
13. Sharma, H. W., and Narayanan, R. The NF-κB transcription factor in oncogenesis. Anticancer Res., 16: 589-596, 1996.
14. Luque, I., and Gélinas, C. Rel/NF-κB, and IκB factors in oncogenesis. Semin. Cancer Biol., 8: 103-111, 1997.
15. Gilmore, T. D., Koedood, M., Piffat, K. A., and White, D. W. Rel/NF-κB/IκB proteins and cancer. Oncogene, 13: 1367-1378, 1996.
16. Baldwin, A. S., Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol., 14: 649-683, 1996.
17. Takeshita, H., Yoshizaki, T., Miller, W. E., Sato, H., Furukawa, M., Pagano, J. S., and Raab-Traub, N. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J. Virol., 73: 5548-5555, 1999.
18. Sato, H., Kita, M., and Seiki, M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem., 268: 23460-23468, 1993.
19. Mukaida, N., Okamoto, S., Ishikawa, Y., and Matsushima, K. Molecular mechanism of interleukin-8 gene expression. J. Leukoc. Biol., 56: 554-581, 1994.
20. Vilarete, L. H., and Remick, D. G. Transcriptional and post-transcriptional regulation of interleukin-8. Am. J. Pathol., 149: 1685-1693, 1996.
21. Barnes, P. J., and Karin, M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336: 1066-1071, 1997.
22. Brockman, J. A., Scherer, D. C., McKinsey, T. A., Hall, S. M., Qi, X., Lee, W. Y., and Ballard, D. W. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol., 15: 2809-2818, 1995.
23. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Washington DC), 267: 1485-1488, 1995.
24. Traenckner, E. B., Pahl, H. L., Henkel, T., Schmidt, K. N., Wilk, S., and Baeuerle, P. A. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J., 14: 2876-2883, 1995.
25. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science (Washington DC), 274: 787-789, 1996.
26. Wang, C. Y., Mayo, M. W., and Baldwin, A. S. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science (Washington DC), 274: 784-787, 1996.
27. Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., and Baldwin, A. S., Jr. A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev., 12: 968-981, 1998.
28. Duffey, D. C., Chen, Z., Dong, G., Ondrey, F. G., Wolf, J. S., Brown, K., Siebenlist, U., and Waes, C. V. Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression and tumor growth in vivo. Cancer Res., 59: 3468-3474, 1999.
29. Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., Jr., and Sledge, G. W., Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol., 17: 3629-3639, 1997.
30. Wang, W., Abbruzzese, J. L., Evans, D. B., Larry, L., Cleary, K. R., and Chiao, P. J. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res., 5: 119-127, 1999.
31. Shattuck-Brandt, R. L., and Richmond, A. Enhanced degradation of I-κBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells. Cancer Res., 57: 3032-3039, 1997.
32. Dong, G., Chen, Z., Koto, T., and Van Waes, C. The host environment promotes the constitutive activation of nuclear factor-κB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. Cancer Res., 59: 3495-3504, 1999.
33. Kozlowski, J. M., Hart, I. R., Fidler, I. J., and Hanna, N. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Cancer Inst., 72: 913-917, 1984.
34. Li, L., Price, J. E., Fan, D., Zhang, R. D., Bucana, C. D., and Fidler, I. J. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. J. Natl. Cancer Inst., 81: 1406-1412, 1989.
35. Luca, M., Huang, S., Gershenwald, J. E., Singh, R. K., Reich, R., and Bar-Eli, M. Expression of interleukin-8 by human melanoma cells upregulates MMP-2 activity and increases tumor growth and metastasis. Am. J. Pathol., 151: 1105-1113, 1997.
36. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., and Karin, M. A Cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature (Lond.), 388: 548-554, 1997.
37. DiDonato, J. A., Mercurio, F., and Karin, M, Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell. Biol., 75: 1302-1311, 1995.
38. Huang, S., Jean, D., Luca, M., Tainsky, M. A., and Bar-Eli, M. Loss of AP-2 results in downregulation of c-kit and enhancement of melanoma tumorigenicity and metastasis. EMBO J., 17: 4358-4369, 1998.
39. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-990, 1989.
40. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
41. Alley, M. C., Scudiero, D. A., Monks, A., Hersey, M. L., Czerwinski, M. J., Fine, D. L., Abbot, B. J., Mayo, J. G., Shoemarker, R. H., and Boyd, M. R. Feasibility of drug screening with panels of human tumor cell line using a microculture tetrazolium assay. Cancer Res., 48: 589-602, 1988.
42. Veechi, A., Garlanda, C., Lampugnani, M. G., Resnati, M., Matteucci, C., Stoppacciaro, A., Schnurch, H., Risau, W., Ruco, L., and Mantovani, A. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Eur. J. Cell Biol., 63: 247-254, 1994.
43. Bielenberg, D. R., Bucana, C. D., Sanchez, R., Donawho, C. K., Kripke, M. L., and Fidler, I. J., Molecular regulation of UVB-induced cutaneous angiogenesis. J. Investig. Dermatol., 111: 864-872, 1998.
44. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
45. Beg, A. A., and Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Washington DC), 274: 782-784, 1996.
46. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., and Stricter, R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Washington DC), 258: 1798-1801, 1992.
47. Strieter, R. M., Kunkel, S. L., Elner, V. M., Martonyi, C. L., Koch, A. E., Polverini, P. J., and Elner, S. G. Interleukin-8: a corneal factor that induces neovascularization. Am. J. Pathol., 141: 1279-1284, 1992.
48. Hu, D. E., Hori, Y., and Fan, T. P. Interleukin-8 stimulates angiogenesis in rats. Inflammation, 17: 135-143, 1993.
49. Norrby, K. Interleukin-8 and de novo mammalian angiogenesis. Cell Prolif., 29: 315-319, 1996.
50. Gutman, M., Singh, R. K., Xie, K., Bucana, C. D., and Fidler, I. J. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res., 55: 2470-2475, 1995.
51. Koong, A. C., Chen, E. Y., and Giaccia, A. J. Hypoxia causes the activation of nuclear factor KB through the phosphorylation of IκBα on tyrosine residues. Cancer Res., 54: 1425-1430, 1994.
52. Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., and Baldwin, A. S., Jr. Oncogenic Ha-Ras-induced signaling activates NF-κB transcriptional activity, which is required for cellular transformation. J. Biol. Chem., 272: 24113-24116, 1997.
53. Higgins, K. A., Perez, J. R., Coleman, T. A., Dorshkind, K., McComas, W. A., Sarmiento, U. M., Rosen, C. A., and Narayanan, R. Antisense inhibition of the p65 subunit of NF-κB blocks tumorigenicity and causes tumor regression. Proc. Natl. Acad. Sci. USA, 90: 9901-9905, 1993.
54. Wang, W., Abbruzzese, J. L., Evans, D. B., and Chiao, P. J. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. Oncogene, 18: 4554-4563, 1999.
55. Yoshida, A., Yoshida, S., Khalil, A. K., Ishibashi, T., and Inomata, H. Role of NF-κB-mediated interleukin-8 expression in intraocular neovascularization. Investig. Ophthalmol. Visual Sci., 39: 1097-1106, 1998.
56. Yoshida, A., Yoshida, S., Ishibashi, T., Kuwano, M., and Inomata, H. Suppression of retinal neovascularization by the NF-κB inhibitor pyrrolidine dithiocarbamate in mice. Investig. Ophthalmol. Visual Sci., 40: 1624-1629, 1999.
57. Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., Suzuki, H., and Kuwano, M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell. Biol., 17: 4015-4023, 1997.
58. Shono, T., Ono, M., Izumi, H., Jimi, S. I., Matsushima, K., Okamoto, T., Kohno, K., and Kuwano, M. Involvement of the transcription factor NF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol. Cell. Biol., 16: 4231-4239, 1996.
59. Singh, R. K., Gutman, M., Radinsky, R., Bucana, C. D., and Fidler, I. J. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res., 54: 3242-3247, 1994.
60. Miller, L. J., Kurtzman, S. H., Wang, Y., Anderson, K. H., Lindquist, R. R., and Kreutzer, D. L. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res., 18: 77-81, 1998.